Thus, when blood monocytes attracted to the TME differentiate into tumour-associated macrophages (TAM) they can provide either anti-tumour (M1) or tumour-promoting activity (M2) as driven respectively by the local levels of IFN gamma versus IL-4/IL-13 [66]. This evidence concerns the gene IL13 and neoplasm.